HK1039745A1 - 用於改善識別的非典型抗精神病藥和乙酰膽碱酯酶 - Google Patents

用於改善識別的非典型抗精神病藥和乙酰膽碱酯酶

Info

Publication number
HK1039745A1
HK1039745A1 HK02100158.6A HK02100158A HK1039745A1 HK 1039745 A1 HK1039745 A1 HK 1039745A1 HK 02100158 A HK02100158 A HK 02100158A HK 1039745 A1 HK1039745 A1 HK 1039745A1
Authority
HK
Hong Kong
Prior art keywords
combination
acetylcholinesterase inhibitor
atypical antipsychotic
improving cognition
cognition
Prior art date
Application number
HK02100158.6A
Other languages
English (en)
Inventor
Leonce Irma De Nijs Paul
Louis Julien Parys Wim
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of HK1039745A1 publication Critical patent/HK1039745A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
HK02100158.6A 1998-10-16 2002-01-10 用於改善識別的非典型抗精神病藥和乙酰膽碱酯酶 HK1039745A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98203454 1998-10-16
PCT/EP1999/007804 WO2000023057A2 (en) 1998-10-16 1999-10-12 Atypical antiphsychotic in combination with acetylcholinesterase inhibitor for improving cognition

Publications (1)

Publication Number Publication Date
HK1039745A1 true HK1039745A1 (zh) 2002-05-10

Family

ID=8234219

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02100158.6A HK1039745A1 (zh) 1998-10-16 2002-01-10 用於改善識別的非典型抗精神病藥和乙酰膽碱酯酶

Country Status (20)

Country Link
EP (1) EP1121131A2 (zh)
JP (1) JP2002527469A (zh)
KR (1) KR20010072878A (zh)
CN (1) CN1367697A (zh)
AU (1) AU6472799A (zh)
BG (1) BG105302A (zh)
BR (1) BR9914419A (zh)
CA (1) CA2345767A1 (zh)
EE (1) EE200100136A (zh)
HK (1) HK1039745A1 (zh)
HR (1) HRP20010262A2 (zh)
HU (1) HUP0103781A3 (zh)
ID (1) ID28441A (zh)
IL (1) IL142588A0 (zh)
NO (1) NO20011403D0 (zh)
PL (1) PL348107A1 (zh)
SK (1) SK4592001A3 (zh)
TR (1) TR200101082T2 (zh)
WO (1) WO2000023057A2 (zh)
ZA (1) ZA200103081B (zh)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0102841D0 (en) * 2001-02-05 2001-03-21 Novartis Ag Organic compounds
AU2006201188B2 (en) * 2001-02-05 2007-11-15 Novartis Ag New use of iloperidone
ES2358416T3 (es) 2001-10-30 2011-05-10 Novartis Ag Formulaciones de liberación prolongada de iloperidona y polímero en forma de estrella.
GB0216416D0 (en) 2002-07-15 2002-08-21 Novartis Ag Organic compounds
US20040192754A1 (en) * 2003-03-24 2004-09-30 Shapira Nathan Andrew Methods for treating idiopathic hyperhidrosis and associated conditions
TW200501962A (en) * 2003-04-01 2005-01-16 Novartis Ag Use of carbamazepine derivatives for the treatment of agitation in dementia patients
WO2005065645A2 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Donepezil formulations
JP2008523058A (ja) * 2004-12-10 2008-07-03 アボット・ラボラトリーズ 縮合ビシクロ複素環置換キヌクリジン誘導体
WO2008055945A1 (en) 2006-11-09 2008-05-15 Probiodrug Ag 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
US9126987B2 (en) 2006-11-30 2015-09-08 Probiodrug Ag Inhibitors of glutaminyl cyclase
CN101668525A (zh) 2007-03-01 2010-03-10 前体生物药物股份公司 谷氨酰胺酰环化酶抑制剂的新用途
EP2142514B1 (en) 2007-04-18 2014-12-24 Probiodrug AG Thiourea derivatives as glutaminyl cyclase inhibitors
MX2007008642A (es) * 2007-07-16 2009-02-25 World Trade Imp Export Wtie Ag Composicion farmaceutica que comprende la combinacion de un agente derivado benzisoxazolico y un agente inhibidor reversible de la enzima colinesterasa, indicada para el control y tratamiento de trastornos psicoticos y demencias.
BR112012019923A2 (pt) 2010-02-09 2016-08-09 Univ Johns Hopkins métodos e composições para melhorar a função cognitiva
ES2586231T3 (es) 2010-03-03 2016-10-13 Probiodrug Ag Inhibidores de glutaminil ciclasa
DK2545047T3 (da) 2010-03-10 2014-07-28 Probiodrug Ag Heterocycliske inhibitorer af glutaminylcyclase (QC, EC 2.3.2.5)
WO2011131748A2 (en) 2010-04-21 2011-10-27 Probiodrug Ag Novel inhibitors
ES2570167T3 (es) 2011-03-16 2016-05-17 Probiodrug Ag Derivados de benzimidazol como inhibidores de glutaminil ciclasa
CA2891122C (en) 2012-11-14 2021-07-20 The Johns Hopkins University Methods and compositions for treating schizophrenia
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
EP2968220B1 (en) 2013-03-15 2021-05-05 Agenebio, Inc. Methods and compositions for improving cognitive function
CN107810002B (zh) 2015-05-22 2021-01-05 艾吉因生物股份有限公司 左乙拉西坦的延时释放药物组合物
PL3461819T3 (pl) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitory cyklazy glutaminylowej

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336675A (en) * 1991-05-14 1994-08-09 Ernir Snorrason Method of treating mania in humans
DK0584185T3 (da) * 1991-05-14 2000-02-07 Ernir Snorrason Behandling af træthedssyndrom med cholinesteraseinhibitorer
CA2300148C (en) * 1997-08-11 2009-06-23 University Of South Florida Nicotine antagonists for nicotine-responsive neuropsychiatric disorders
PT1073432E (pt) * 1998-04-14 2007-10-22 Gen Hospital Corp Utilização da d-alanina ou da d-serina para o tratamento da esquizofrenia

Also Published As

Publication number Publication date
CN1367697A (zh) 2002-09-04
TR200101082T2 (tr) 2001-09-21
SK4592001A3 (en) 2001-12-03
NO20011403L (no) 2001-03-20
ZA200103081B (en) 2002-07-12
NO20011403D0 (no) 2001-03-20
JP2002527469A (ja) 2002-08-27
BR9914419A (pt) 2001-06-26
HUP0103781A2 (hu) 2002-03-28
WO2000023057A3 (en) 2000-07-27
IL142588A0 (en) 2002-03-10
EE200100136A (et) 2002-06-17
PL348107A1 (en) 2002-05-06
CA2345767A1 (en) 2000-04-27
WO2000023057A2 (en) 2000-04-27
AU6472799A (en) 2000-05-08
HRP20010262A2 (en) 2002-06-30
EP1121131A2 (en) 2001-08-08
BG105302A (en) 2001-11-30
HUP0103781A3 (en) 2003-09-29
ID28441A (id) 2001-05-24
KR20010072878A (ko) 2001-07-31

Similar Documents

Publication Publication Date Title
HK1039745A1 (zh) 用於改善識別的非典型抗精神病藥和乙酰膽碱酯酶
PL352680A1 (en) Benzothiazinone and benzoxazinone compounds
EP1233007A4 (en) INTERMEDIATE LAYER FOR COMPOSITE GLASS AND COMPOSITE GLASS
GB2335416B (en) Coverable container
HK1034818A1 (en) Inverter
EP1312379A4 (en) FIBRINOGENIC REDUCTION AGENTS
GB2337093B (en) Table construction
GB2345528B (en) Annealing welded parts
GB0025569D0 (en) Cold box
GB9817085D0 (en) Drinks bottle accessory
EP1306903A4 (en) INVERTER
GB0003496D0 (en) Improved worktable
GB9900182D0 (en) Combination continental quilt
GB9820159D0 (en) Resealable beverage can
GB9922674D0 (en) Key tappers
GB9804075D0 (en) Disgorger torch
PL328097A1 (en) Regenerative beverage of high calorific value
LT98105A (en) Composition for alcoholic beverage
LT98156A (en) Alcoholic beverage composition
GB0024847D0 (en) Inverter
CA82933S (en) Beverage can
TW345001U (en) Wine pot
PL108743U1 (en) Table-dispenser for beverages
GB9807307D0 (en) Wine warmer
PL324941A1 (en) Combination transformer